Singapore markets open in 6 hours 9 minutes

ABBV Jan 2023 185.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.01000.0000 (0.00%)
As of 11:15AM EDT. Market open.
Full screen
Previous close0.0100
Open0.0100
Bid0.1300
Ask0.6200
Strike185.00
Expiry date2023-01-20
Day's range0.0100 - 0.0100
Contract rangeN/A
Volume8
Open interest1.69k
  • Motley Fool

    3 Dividend Aristocrats In Warren Buffett's Secret Portfolio You Can Buy Right Now

    A little-known group of Buffett stocks includes three members of dividend royalty with solid growth prospects.

  • Motley Fool

    Is AbbVie a Buy?

    Drugmaker AbbVie (NYSE: ABBV) is one of the largest healthcare stocks in the world, with a market cap of over $250 billion. AbbVie last reported its earnings in July. Humira remains key to AbbVie's business for now, generating $5.4 billion this past quarter, nearly three times the $1.8 billion Skyrizi and Rinvoq generated.

  • Motley Fool

    Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond

    Let's look at two biotech stocks that look attractive at current levels: AbbVie (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD). AbbVie is one of the largest pharmaceutical companies around. Like other drugmakers, AbbVie benefits from the fact that doctors do not stop prescribing lifesaving drugs even during challenging economic times, nor do patients stop taking them.